Our data provide evidence that the neuroblastoma CRC, operating through an LMO1-ASCL1 axis, not only promotes the growth and survival of malignant neuroblasts, but also blocks the differentiation of sympathetic progenitor cells. This evidence concerns the gene ASCL1 and colorectal carcinoma.